The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.
This study uncovers how trauma, isolation, loss of identity, and lack of support can overlap and amplify each other, deepening despair and driving suicide risk among women in the perinatal period.
If you or someone you know is in crisis, confidential support is available.
Folic Acid Awareness Week (Sept 7–14, 2025) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; Dr. Freeman weighs in on the information provided in the report.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
While the 2025 report indicates that the United States has made progress in training and deploying more maternal mental health providers, the risk for maternal mental health disorders is actually rising.
By implementing trauma-informed strategies, healthcare providers can help create a safe and supportive environment for sexual trauma survivors during pregnancy, labor, and delivery.
This article explores the case of a woman with bipolar disorder who develops HG associated with severe anxiety and sleep disruption, and discusses various treatment options.
